Global Neurodiagnostics Market to Reach $13.7 Billion by 2030
The global market for Neurodiagnostics estimated at US$7.5 Billion in the year 2022, is projected to reach a revised size of US$13.7 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2022-2030. Diagnostic Imaging Systems, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the In-vitro diagnostics (IVD) segment is readjusted to a revised 7.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 12.3% CAGR
The Neurodiagnostics market in the U.S. is estimated at US$2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.Select Competitors (Total 33 Featured) -
- Advanced Brain Monitoring
- ANT Neuro
- Bio-Rad Laboratories
- Canon, Inc.
- DRG Instruments GmbH
- Elmiko Medical Sp. Z o.o.
- Fonar Corporation
- Fujifilm Holdings Corporation
- Fujirebio
- GE Healthcare
- Hitachi, Ltd.
- Hoffman-La Roche AG
- Lifelines Neuro Company, LLC
- Mitsar Co., Ltd.
- Motion Lab Systems, Inc.
- Natus Medical Incorporated
- Neusoft Medical Systems Co., Ltd.
- Nihon Kohden Corporation
- Philips Healthcare
- Qiagen N.V.
- Ridge Diagnostics
- Rigaku Corporation
- Siemens Healthineers
- Tecan Trading AG
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Brain Monitoring
- ANT Neuro
- Bio-Rad Laboratories
- Canon, Inc.
- DRG Instruments GmbH
- Elmiko Medical Sp. Z o.o.
- Fonar Corporation
- Fujifilm Holdings Corporation
- Fujirebio
- GE Healthcare
- Hitachi, Ltd.
- Hoffman-La Roche AG
- Lifelines Neuro Company, LLC
- Mitsar Co., Ltd.
- Motion Lab Systems, Inc.
- Natus Medical Incorporated
- Neusoft Medical Systems Co., Ltd.
- Nihon Kohden Corporation
- Philips Healthcare
- Qiagen N.V.
- Ridge Diagnostics
- Rigaku Corporation
- Siemens Healthineers
- Tecan Trading AG
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 7.5 Billion |
Forecasted Market Value ( USD | $ 13.7 Billion |
Compound Annual Growth Rate | 7.8% |
Regions Covered | Global |